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Abstract
Objectives To investigate the added advantage of IV furosemide
injection and the subsequent urine dilution in the detection of
urinary calculi in the excretory phase of dual-source dual-energy
(DE) computed tomography (CT) urography, and to investigate
the feasibility of characterising the calculi through diluted urine.
Methods Twenty-three urinary calculi were detected in 116
patients who underwent DECT urography for macroscopic
haematuria with a split bolus two- or three-acquisition protocol,
including a true unenhanced series and at least a mixed
nephrographic excretory phase. Virtual unenhanced images
were reconstructed from contrast-enhanced DE data. Calculi
were recorded on all series and characterised based on their X-
ray absorption characteristics at 100 kVp and 140 kVp in both
true unenhanced and nephrographic excretory phase series.
Results All calculi with a diameter more than 2 mmwere detect-
ed in the virtual unenhanced phase and in the nephrographic
excretory phase. Thirteen of these calculi could be characterised
in the true unenhanced phase and in the mixed nephrographic
excretory phase. The results were strictly identical for both phases,
six of them being recognised as non-uric acid calculi and seven as
uric acid calculi.
Conclusions Mixed nephrographic excretory phase DECTafter
furosemide administration allows both detection and characteri-
sation of clinically significant calculi, through the diluted urine.
Key points
• Urinary tract stones can be detected on excretory phase
through diluted urine.
• Urinary tract stone characterisation with dual-energy CT
(DECT) is possible through diluted urine.
• A dual energy split-bolus CT urography simultaneously en-
ables urinary stone detection and characterisation.
Keywords Dual-energy CT (DECT) urography . Split-bolus
CTurography protocol . Furosemide . Urinary stones
composition . Urinary stones detection
Introduction
Computed tomography (CT) urography is the diagnostic method
of choice for the investigation of haematuria [1]. Urinary tract
calculi are the most frequent cause of haematuria, urinary tract
infection excluded, in patients less than 40 years old, with no risk
factors for malignancy. For the detection of calculi in this patient
group, an unenhanced low-dose CT of kidneys, ureters and
bladder is the imaging method of choice. CT urography is
significantly inferior to unenhanced CT for the detection of
urinary calculi [1]. In order to decide which patient should
undergo which imaging examination, the radiologist often faces
a dilemma and, frequently, even if calculi are detected on the
unenhanced CT, the work schedule will continue, with one or
more acquisitions after intravenous iodinated contrast material
injection, for the detection of an eventual tumoural lesion. If all
clinically important information concerning urinary calculi could
be acquired from one enhanced series only, the unenhanced
acquisition could be skipped.
Dual-source dual-energy (DE) CT has the ability to create
virtual unenhanced images on the basis of data from the en-
hanced acquisition. However, in the late excretory phase of CT
urography, urine in the collecting system is densely opacified.
Virtual unenhanced images of the late excretory phase are of
suboptimal quality because of the densely opacified urine. For
this reason, virtual unenhanced imaging from the excretory
phase acquisition has been shown to be of moderate accuracy
in the detection of urinary calculi [2].
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Dual-source DECT has been shown to accurately charac-
terise calculi according to their chemical composition, based
on their absorption characteristics of X-rays at different kVp
settings on unenhanced studies [3–5].
In the excretory phase of a standard CT urography, calculi
are surrounded by urine with similar densities. Because of this,
and because of a partial volume effect at the periphery of the
calculus, characterisation is impossible. Densely opacified urine
has been shown in vitro to pose an obstacle to characterising the
calculi, especially the smallest ones [6].
Intravenous (IV) furosemide administration, before the ac-
quisition of excretory phase CT urography, results in a lower
contrast density of the opacified urine in the collecting system.
The purpose of this study was to investigate the added
advantage of IV furosemide injection and the subsequent urine
dilution, in the detection of urinary calculi in the excretory
phase of dual-source DECT urography and to investigate the
feasibility of characterising the calculi through diluted urine.
Materials and methods
Patient population
The study was approved by the ethics committee of our
hospital.
The DECT urographies of 120 consecutive adult patients
performed in our hospital from September 2011 to August
2012 were reviewed retrospectively.
The indications for the examination were: macroscopic
haematuria (43), microscopic haematuria (1), investigation
of known or suspected renal tumour (15), suspicion, follow-
up or extension control of urothelial cancer (41), morpholog-
ical control in the case of persistent urinary tract infections or
obstructive semiology (12), investigation of known or clinical
suspicion of urinary tract calculi (4) and other (4).
CT urography is not performed in our hospital in the follow-
ing patients: pregnant women, patients aged below 18 years, and
those with acute renal colic. Furosemide is not injected into
patients with hypotension and known allergy to sulphonamides.
Four patients in total were excluded: three of them because
of significant artefacts generated from bilateral hip prostheses
and one because of utilisation of a different protocol by the
referring radiographer. The remaining 116 patients formed the
population of the study (92 men and 24 women; mean age
70.22±14.27 years; age range 19–99). The mean bodyweight
of the patients was 75.22±14.13 kg. The patients’ mean BMI
was 26.2±4.61.
Imaging protocol
DECTurography was performed on a second generation dual-
source DECT system (SOMATOMDefinition Flash; Siemens
Healthcare, Forchheim, Germany), using an unenhanced and
one- or two-phase enhanced acquisitions protocol, according
to the clinical setting. The examination protocol was as fol-
lows. Patients emptied their bladder just before the examina-
tion. First, unenhanced DECT acquisitions of the abdomen and
pelvis were obtained. All patients were subsequently adminis-
tered 20 mg furosemide (Lasix; Sanofi Aventis, Laval, Quebec,
Canada) intravenously and 1 min later a dose of 1.2 ml/kg
Iohexol (Accupaque 350; GE Healthcare, Milwaukee, WI,
USA) intravenously at a rate of 2 ml/s. For the three-
acquisition protocol, a late arterial corticomedullary phase acqui-
sition of the abdomen and pelvis was obtained 35 s after the
beginning of the contrast medium injection. A second injection
of 0.8 ml/kg of the same contrast agent at the same rate followed
7 min after the first injection and a mixed nephrographic excre-
tory imaged series was obtained 100 s after the beginning of the
second contrast bolus injection, for both protocols.
In total, six patients underwent imaging with the two-
acquisitions and 110 with the three-acquisition protocol.
The acquisition parameters for all phases were: DE mode
with one tube at 100 kVp and the other at 140 kVp, current
modulation (4D care dose ®) with reference 250 mAs for the
100 kVp tube, collimation of 32×2×0.625 mm, gantry rotation
time 0.5 s and a pitch of 0.6. All three acquisitions were
reconstructed as 2-mm-thick sections. Radiation dose was cal-
culated for each acquisition separately and was expressed in
mSv. These values were estimated by multiplying the total
dose–length product provided by the CTconsole for each acqui-
sition, by a normalising coefficient of 0.015.
Image analysis
All DECT urography examinations were transferred on an
independent workstation (Syngo DE; Siemens Healthcare,
Erlangen Germany) and evaluated on consensus by two radi-
ologists (11 and 3 years of experience in genitourinary radi-
ology), who were blinded for series technique, patients iden-
tities and the final diagnosis as established from the true
unenhanced series that was used as a “gold standard”.
Calculus detection
In the reading of DECT urography examinations the two readers
evaluated in consensus the unenhanced series, the virtual
unenhanced series issuing from the mixed nephrographic excre-
tory acquisition and the mixed nephrographic excretory series
without iodine subtraction for the presence of urinary tract calculi.
Virtual unenhanced images were obtained from the mixed
nephrographic excretory DE acquisition by using the “liver
VNC” algorithm of the SyngoDE software.
All series were evaluated on the axial plane with the help of
any additional multiplanar or three-dimensional reconstructions
if necessary. Window settings were freely changed according to
710 Eur Radiol (2014) 24:709–714
the excreted contrast densities and consequently were different
for each examination. When a calculus was found, its position
was noted after dividing the urinary tract into seven anatomical
segments: 1, precalyceal or calyceal; 2, renal pelvic; 3, proximal
ureteral; 4, middle ureteral; 5, distal ureteral; 6, ureterovesical
junction (UVJ); 7, intra-vesical.
The maximal diameters of the calculi were also noted,
measured in the axial plane, with bone window settings (win-
dow level 300 HU; window width 1,500 HU).
Characterisation of the calculi
When a calculus was detected in either the unenhanced or the
mixed nephrographic pyelographic phase, the data of the
corresponding DE series were further reconstructed using
the “kidney stone” algorithm of Syngo DE software.
This software attributed two different coloured overlays to
different calculi, according to their chemical composition: red
for uric acid and blue for non-uric acid. The material decom-
position achieved by this software is based on the different
absorption of X-rays of different energies.
Results of calculus characterisation on the basis of the
mixed nephrographic excretory acquisition were compared
with those of characterisation on the basis of the unenhanced
DE acquisition.
Statistical analysis
Statistical analysis was performed with Prism (Prism, version
5d, 2010; GraphPad Software, San Diego, CA, USA) and
Microsoft Excel (Excel for MAC version 14.3.4, 2011;
Microsoft Corporation, Redmond, Washington, USA). For
continuous values, the results are presented as mean ± stan-
dard error. Normally distributed data sets, established by the
Kolmogorov-Smirnov test, were compared using Student’s t -
test. Two-sided testing was used. Differences were considered
significant at P <0.05.
Results
Of the 116 patients included in the study, ten patients had a total
of 23 calculi detected on the unenhanced phase. The mean size
of the calculi was 6.46±3.77 mm (range 1.3–13mm). Twelve of
these calculi were of precalyceal or calyceal localisation (mean
size 3.89±2.11 mm; range 1.3–7.3 mm). Seven were located in
the bladder (mean size 10.9±2.02 mm; range 7.3–13 mm). Two
were found in the renal pelvis and measure 4.9 and 3.5 mm; one
was localised on the UVJ (8 mm) and one in the distal ureter
(7.5 mm).
Of these calculi, 18 were detected on the virtual unenhanced
series; mean size 7.3±3.2 mm; range 3.3–11.8 mm (seven
calyceal, seven in the bladder, two in the renal pelvis, one in the
distal ureter and one in the UVJ). Overall sensitivity was 78.2 %;
for calculi ≥2 mm, sensitivity was 100 % (Table 1). The five
calculi that were not detected on the virtual unenhanced series
measured ≤2 mm and were of calyceal or precalyceal location.
In the mixed nephrographic excretory series, 20 calculi in
total were identified with a mean size of 6.8±3.7 mm (nine
calyceal, seven in the bladder, two in the renal pelvis, one in
the distal ureter and one in the UVJ). Overall sensitivity was
86.9 %; for calculi ≥2 mm, sensitivity was 100 % (Table 1).
The three calculi missed by this series measured ≤2 mm and
were of calyceal or precalyceal location.
Thirteen of the calculi could be characterised in the true
unenhanced and the nephrographic excretory phase and the results
were strictly identical for both series, six of them being identified
as non-uric acid calculi (Fig. 1) and seven as uric acid calculi
(Fig. 2). The mean size of these 13 calculi was 8.49±3.07 mm;
range 3.5–13mm and was significantly higher than the size of the
calculi that could not be characterised by DECT (2.91±1.58;
range 1.3–6 mm; P=0.000017).
Mean radiation doses were 9.077±2.917, 9.468±3.045 and
9.326±2.902 mSv respectively for unenhanced, corticomedullary
and mixed nephrographic excretory phases.
Discussion
Detection of urinary calculi in opacified urine by using DECT
has been previously reported, with suboptimal results; overall
sensitivity for detecting calculi was 63% (27 out of 43 calculi)
per calculus [7]. In another study, sensitivity of the virtual
unenhanced series for calculi was found to be moderate, even
for calculi larger than 2.9 mm (76 %) [8]. This was probably
due to dense contrast-enhanced urine surrounding calculi and
creating a partial volume effect, resulting in oversubtraction
and thus elimination of calculi, or insufficient subtraction of
iodine. Karlo et al. [9], in a recent study, reported better results
for the virtual unenhanced series reconstructed from the mixed
nephrographic excretory phase. In this study, 83 % of calculi
were detected. Missed calculi had a mean size of 2.5 mm
(range 1-4 mm) and were significantly smaller than the calculi
correctly identified. In our study, the missed calculi were all
Table 1 Overall sensitivities and sensitivities for calculi greater than
2 mm for the unsubtracted mixed nephrographic excretory phase and
the corresponding virtual unenhanced image series
Sensitivities of different series for stone detection
Overall sensitivity Sensitivity for stones ≥2 mm
Unsubtracted
mixed
Virtual
unenhanced
Unsubtracted
mixed
Virtual
unenhanced
86.9 % 78.2 % 100 % 100 %
20/23 stones 18/23 stones 18/18 stones 18/18 %
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less than 2 mm. The reason for this might be contrast dilution
in urine due to furosemide injection. Of course, our study
includes a limited number of calculi and further research is
needed in the domain.
Fig. 1 Dual energy (DE) CT
urography of a 55-year-old man
with macrohaematuria. Coronal
CT reconstructions show an
inferior calyceal group stone of
the left kidney in the true
unenhanced series (white arrow
in a), characterised as a non-uric
acid stone by the dedicated
software based on the data of this
true unenhanced acquisition
(white arrow in b). The same
calculus is visible on the coronal
reconstructions of the mixed
nephrographic excretory phase
through diluted urine (white
arrow in c) and characterised as a
non-uric acid calculus based on
this image series (white arrow in
d)
Fig. 2 DECT urography of a 67-
year-old man with known bladder
cancer. Axial plane CT showing a
bladder calculus in the true
unenhanced series (white arrow
in a), characterised as a uric acid
calculus based on the true
unenhanced series (white arrow
in b). The same calculus shown
on the mixed nephrographic
excretory phase through diluted
urine (white arrow in c) and
characterised as a uric acid
calculus based on the mixed
nephrographic excretory phase
(white arrow in d). Notice the
extensive bladder cancer on the
posterior left lateral bladder wall
shown on all four figures and the
presence of air in the non-
dependent part of the bladder due
to cystoscopy immediately before
the CT examination
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In our study, the overall sensitivity for calculus detection was
better for unsubtracted mixed nephrographic excretory phase
(86.9 %, 20 out of 23 calculi) than in the virtual unenhanced
series (Table 1). Scheffel et al. [10] found in the same way that
virtual unenhanced images created from nephrographic phase
CT images had a sensitivity of 74% (26 out of 35 calculi) while
the original unsubtracted nephrographic phase images had a
sensitivity of 94 % (33 out of 35 calculi). Thus from both
studies it was shown that virtual unenhanced images have no
added value in calculus detection compared with the original
unsubtracted CT acquisitions neither in the nephrographic
phase alone nor in the mixed nephrographic excretory phase
with urine dilution.
Both unsubtracted mixed nephrographic excretory phase and
virtual unsubtracted series detected all calculi ≥2 mm. It is
accepted that up to 98 % of calculi less than 5 mm, especially
in the distal ureter may be expected to pass spontaneously [11].
Therefore, according to the guideline of the American Urological
Association, observation is the initial treatment of these calculi
[11]. However, even small calculi can be the cause of haematuria,
but calculi less than 8 mm are less frequently associated with this
condition [12]. Despite these facts, clinicians should be informed
concerning the lower sensitivity of enhanced DECT for calculi
less than 2mm.UnenhancedCT has also been shown to have the
potential to predict calculus formation, by measuring the density
to the tip of the papillae [13] with a mean density of 45.2 vs 32.1
HU for the calculus-forming group of patients versus the normal
subjects. Virtual unenhanced series is probably inadequate for the
detection of such subtle differences. For these indications as well
as for the detection of precalyceal or calyceal calculi less than
2mm, alternatively, an unenhanced CT limited to the kidneys for
the detection of microlithiasis can be proposed for the DECT
protocol in the clinical context of haematuria.
In our protocol, urine dilution resulting from furosemide
injection prior to the examination could also have potential
benefits by facilitating automated calculus size measurements
by recently developed algorithms [14] that cannot be applied
to conventional pyelographic CT acquisitions where the cal-
culus is surrounded by dense urine. The application of these
algorithms to the unsubtractedmixed nephrographic excretory
phase or even to the corresponding virtual unenhanced series
can be further investigated.
Characterisation of urine calculi is feasible by using the
DECT data from unenhanced acquisitions [3–5]. Targeted
unenhanced DE acquisitions focused on the calculi, previously
identified by low-dose CT, has also been described in the liter-
ature [15]. To our knowledge, we show in this study for the first
time, in vivo, that calculus characterisation is possible through
mildly opacified urine in the mixed nephrographic excretory
phase with identical results to the true unenhanced series.
Urine calculi characterisation is of major clinical importance,
as the treatment of uric acid calculi consists of chemolysis, by
urine alkalinisation. It is a medical treatment, in contrast to
shock-wave lithotripsy or surgical treatment that is reserved
for non-uric acid calculi [16, 17]. Currently the evaluation of
patients with urinary tract calculi is done by 24-h urine collec-
tion as it allows for calculation of urinary supersaturations for
the various salts associated with lithogenesis [17]. This is an
indirect technique to estimate stone composition. Unenhanced
CT has also been shown to characterise uric acid calculi based
on their densities [18]. To our knowledge, the accuracy of the
two techniques, DECT and unenhanced single-energy CT, for
calculi characterisation has never been compared.
Radiation dose is a major limiting factor for CT urography.
Given the multitude of clinical settings and for dose reduction
purposes, many different CT urography protocols have been
proposed [19] and continue to develop, together with technolog-
ical progress in the domain of CT. Unenhanced CT is needed
mainly for calculi detection and characterisation of renal masses.
The nephrographic phase is particularly helpful for appreciation
of renal masses, while the excretory phase is essentially used for
urothelial tumour detection. Early phase acquisitions, as the so-
called “urothelial phase”, with an acquisition at 60 s after contrast
injection have also been shown to be of great value for the
detection of urothelial tumours by their contrast uptake and have
been proposed as a single-phase CT urography protocol for
haematuria [20]. Split-bolus iodine contrast injection, with a
mixed nephrographic excretory phase, has been widely used
for the same purpose, in order to skip at least one acquisition.
Triple-bolus CT urography has also been mentioned in the
literature, in an effort to minimise radiation dose to the patients
[21]. With the advent of DECT, the possibility of reconstructing
virtual unenhanced series on the basis of the enhanced CT
acquisition offers a potential means to achieve further dose
reduction, by skipping the unenhanced acquisition. According
to many subsequent clinical studies of dual-source DECT, the
radiation doses that the patients are exposed to are similar to
those received during conventional single-energy CT [22]. In our
hospital we performmost CTacquisitions with this particular CT
system in DEmode. This way, we can benefit from the potential
advantages of DECT as metallic artefacts suppression, or even
iodine maps (particularly useful in cases of urothelial or renal
tumours, ambiguous renal cysts or adrenal incidental lesions).
Ascenti et al. [23] proposed a single-phase mixed
nephrographic excretory phase DECT urography protocol,
reporting 85.7 % sensitivity and 98.7 % specificity for urothelial
tumours. In this study, the reconstructed virtual unenhanced
series used for calculus detection had limited value for calculi
less than 2 mm in diameter. The dose reduction by skipping the
unenhanced CT in this study was as high as 45 %. In our study,
we propose eliminating the unenhanced acquisition, thus lower-
ing the overall radiation dose to the patient by a mean of 9.077±
2.917 mSv. This corresponds to 32.6 % or 49.3 % of the total
dose, depending on which CT urography protocol we chose,
according to the patient’s risk factors for developing urothelial or
renal cancer.
Eur Radiol (2014) 24:709–714 713
The major study limitation is the small number of calculi,
despite an adequate patient population. This is explained by
the fact that indications were more focused on haematuria,
urothelial tumours and known or suspected renal tumours.
Therefore, any calculi were more of an incidental finding.
In conclusion, our preliminary results show that with a single
nephrographic excretory phase with urine dilution, we maintain
an excellent sensitivity of 100 % for clinically significant calculi
of more than 2 mm in diameter. At the same time, we can still
characterise calculi based on their composition, using the data of
the DE acquisition. Thus, the unenhanced CT could be skipped
in a DECT urography protocol for patients with haematuria as
the enhanced series provides all the necessary information.
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